CA2414409A1 - Enhancing therapeutic effectiveness of nitric oxide inhalation - Google Patents

Enhancing therapeutic effectiveness of nitric oxide inhalation Download PDF

Info

Publication number
CA2414409A1
CA2414409A1 CA002414409A CA2414409A CA2414409A1 CA 2414409 A1 CA2414409 A1 CA 2414409A1 CA 002414409 A CA002414409 A CA 002414409A CA 2414409 A CA2414409 A CA 2414409A CA 2414409 A1 CA2414409 A1 CA 2414409A1
Authority
CA
Canada
Prior art keywords
inhalation
endotoxin
mice
pulmonary
wild
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002414409A
Other languages
English (en)
French (fr)
Inventor
Kenneth D. Bloch
Fumito Ichinose
Warren M. Zapol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2414409A1 publication Critical patent/CA2414409A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CA002414409A 2000-06-28 2001-06-22 Enhancing therapeutic effectiveness of nitric oxide inhalation Abandoned CA2414409A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/605,900 US6601580B1 (en) 2000-06-28 2000-06-28 Enhancing therapeutic effectiveness of nitric oxide inhalation
US09/605,900 2000-06-28
PCT/US2001/041102 WO2002000175A2 (en) 2000-06-28 2001-06-22 Enhancing therapeutic effectiveness of nitric oxide inhalation

Publications (1)

Publication Number Publication Date
CA2414409A1 true CA2414409A1 (en) 2002-01-03

Family

ID=24425654

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002414409A Abandoned CA2414409A1 (en) 2000-06-28 2001-06-22 Enhancing therapeutic effectiveness of nitric oxide inhalation

Country Status (10)

Country Link
US (2) US6601580B1 (enExample)
EP (1) EP1301076A4 (enExample)
JP (1) JP2004509850A (enExample)
KR (1) KR100849103B1 (enExample)
CN (1) CN100488497C (enExample)
AU (2) AU2001273622B2 (enExample)
CA (1) CA2414409A1 (enExample)
IL (1) IL153702A0 (enExample)
MX (1) MXPA03000182A (enExample)
WO (1) WO2002000175A2 (enExample)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656452B1 (en) 1997-10-21 2003-12-02 The General Hospital Corporation Use of inhaled NO as anti-inflammatory agent
CA2254645A1 (en) * 1998-11-23 2000-05-23 Pulmonox Medical Corporation Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
US20070086954A1 (en) * 1998-11-23 2007-04-19 Miller Christopher C Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
US7516742B2 (en) * 1999-11-24 2009-04-14 Cardinal Health 207, Inc. Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients with intermittent dosing
US7335181B2 (en) * 2000-12-26 2008-02-26 Pulmonox Technologies Corporation Nitric oxide decontamination of the upper respiratory tract
US7122018B2 (en) * 2000-12-26 2006-10-17 Sensormedics Corporation Device and method for treatment of wounds with nitric oxide
US6432077B1 (en) * 2000-12-26 2002-08-13 Sensormedics Corporation Device and method for treatment of surface infections with nitric oxide
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
GB0125357D0 (en) * 2001-10-22 2001-12-12 Univ Brighton Improvements relating to catalytic antioxidants
KR100949318B1 (ko) * 2001-11-29 2010-03-23 사운드 파마슈티칼스 인코퍼레이티드 화학요법의 바람직하지 않은 작용을 개선하기 위한 방법과조성물
DK1471902T3 (da) * 2002-01-04 2014-09-08 Sound Pharmaceuticals Inc Sammensætninger til brug i fremgangsmåder til behandling af høretab
CN1674942A (zh) * 2002-06-21 2005-09-28 联邦高等教育系统匹兹堡大学 氧化氮、血红素加氧酶－1和血红素降解产物的药学用途
US7531133B2 (en) * 2002-09-10 2009-05-12 Pulmonox Technologies Corporation Use of nitric oxide gas in an extracorporeal circuitry to treat blood plasma
US9138707B2 (en) 2002-12-10 2015-09-22 Sy Kimball Portable, nitric oxide generator
SE0300971D0 (sv) * 2003-04-03 2003-04-03 Aga Ab Nitric oxide in treatment of inflammation
ATE372777T1 (de) 2003-07-09 2007-09-15 Us Gov Health & Human Serv Verwendung von nitritsalzen zur behandlung von kardiovaskulären erkrankungen
WO2005077005A2 (en) * 2004-02-04 2005-08-25 The General Hospital Corporation Enhancing the effectiveness of an inhaled therapeutic gas
US8518457B2 (en) * 2004-05-11 2013-08-27 Pulmonox Technologies Corporation Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
CN1950120B (zh) 2004-05-11 2010-10-20 伟亚医疗森迪斯公司 一氧化氮气体的间歇计量
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US20070154570A1 (en) * 2004-09-29 2007-07-05 Miller Christopher C Use of nitric oxide in the treatment and disinfection of biofilms
US20060211745A1 (en) * 2005-03-08 2006-09-21 Sound Pharmaceuticals Incorporated Methods and compositions for treating cancer
WO2006125123A2 (en) * 2005-05-19 2006-11-23 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
WO2007057763A2 (en) * 2005-11-18 2007-05-24 Pulmonox Technologies Corporation Nitric oxide as an anti-viral agent, vaccine and vaccine adjuvant
US8790715B2 (en) 2006-02-16 2014-07-29 Ino Therapeutics Llc Method and apparatus for generating nitric oxide for medical use
WO2007136789A2 (en) * 2006-05-19 2007-11-29 Medimmune, Inc. Methods of preventing, treating or ameliorating enhanced respiratory disease via innate immune mechanisms
FR2902002B1 (fr) * 2006-06-12 2010-08-27 Lvmh Rech Composition cosmetique anti-radicaux libres
US8079998B2 (en) * 2006-10-20 2011-12-20 Pulmonox Technologies Corporation Methods and devices for the delivery of therapeutic gases including nitric oxide
EP2514473A1 (en) * 2006-11-07 2012-10-24 The General Hospital Corporation Nitric oxide delivery device
US20080193566A1 (en) * 2007-02-09 2008-08-14 Miller Christopher C Use of high dose concentrations of gaseous nitric oxide
JP2011503164A (ja) * 2007-11-12 2011-01-27 サムサラ・メディシン・アクチエボラーグ 呼吸障害に関連する方法
EP2237788A4 (en) * 2007-12-27 2013-06-05 Aires Pharmaceuticals Inc COMPOUNDS FOR OBTAINING AEROSOLIZED NITRITE AND NITRIC OXIDE AND USES THEREOF
US8434475B2 (en) 2008-01-31 2013-05-07 Genosys, Inc. Nitric oxide reactor and distributor apparatus and method
US8720436B2 (en) * 2008-01-31 2014-05-13 Genosys, Inc. Nitric oxide gel apparatus and method
US9649467B2 (en) 2008-01-31 2017-05-16 Syk Technologies, Llc Nitric oxide reactor and distributor apparatus and method
US8501090B2 (en) * 2008-03-24 2013-08-06 Christian S. Minton Anti-microbial gas apparatus and method
CA2671029A1 (en) 2009-06-30 2010-12-30 James S. Baldassarre Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
JP5581500B2 (ja) 2010-03-10 2014-09-03 学校法人北里研究所 虚血再灌流障害軽減用治療剤および治療装置
US8685467B2 (en) 2010-08-03 2014-04-01 J. W. Randolph Miller Nitric oxide generation, dilution, and topical application apparatus and method
WO2012131412A2 (en) 2011-03-31 2012-10-04 Szabo Laszlo Gabor Pharmaceutical composition containing no, process for the preparation and use thereof
US9572833B2 (en) 2011-11-07 2017-02-21 The General Hospital Corporation Treatment of red blood cells
US10517817B2 (en) 2013-05-09 2019-12-31 Syk Technologies, Llc Deep topical systemic nitric oxide therapy apparatus and method
EP2908137A1 (en) * 2014-02-14 2015-08-19 Institut Pasteur Methods for in vitro investigating mitochondrial replication dysfunction in a biological sample, kits and uses thereof, therapeutic methods against progeroid-like syndromes or symptomes and screening method for identifying particular protease inhibitor(s) and/or nitroso-redox stress scavenger compound(s)
JP2014141536A (ja) * 2014-05-16 2014-08-07 Kitasato Institute 虚血再灌流障害軽減用治療剤および治療装置
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
AU2016382883A1 (en) * 2015-12-28 2018-07-12 Vero Biotech LLC Method and apparatus for administering nitric oxide with supplemental drugs
US10052348B2 (en) 2016-01-27 2018-08-21 Syk Technologies, Llc Nitric oxide topical application apparatus and methods
CN110198728A (zh) 2016-11-17 2019-09-03 莱诺翁股份有限公司 用谷胱甘肽组合物治疗呼吸道疾病和感染
WO2019099946A1 (en) 2017-11-17 2019-05-23 Renovion, Inc. Stable ascorbic acid compositions and methods of using the same
CN109169638A (zh) * 2018-11-12 2019-01-11 苏州瑞徕生物科技有限公司 一种细胞保存液及其用途
US12459820B2 (en) 2020-06-11 2025-11-04 J. W. Randolph Miller Stabilized and NO2-inhibited nitric oxide generating gels for inhaled nitric oxide therapy
IL313997A (en) 2022-01-04 2024-08-01 Renovion Inc Aqueous solution including glutathione salt

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5570683A (en) 1990-12-05 1996-11-05 The General Hospital Corporation Methods and devices for treating pulmonary vasoconstriction and asthma
DE69127756T2 (de) 1990-12-05 1998-02-05 The General Hospital Corp., Charlestown, Mass. Verwendung von no zur behandlung oder prävention der bronchokonstriktion
US5396882A (en) 1992-03-11 1995-03-14 The General Hospital Corporation Generation of nitric oxide from air for medical uses
US5427797A (en) 1993-04-06 1995-06-27 Brigham And Women's Hospital Systemic effects of nitric oxide inhalation
WO1994022306A1 (en) * 1993-04-06 1994-10-13 Brigham And Womens Hospital Nitric oxide combination therapy
US5728705A (en) 1993-10-04 1998-03-17 The Trustees Of Columbia University In The City Of New York Method of inducing vasorelaxation to treat pulmonary hypertension
US6063407A (en) * 1995-02-16 2000-05-16 The General Hospital Corporation Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
US5823180A (en) 1995-04-03 1998-10-20 The General Hospital Corporation Methods for treating pulmonary vasoconstriction and asthma
AU6031096A (en) * 1995-06-05 1996-12-24 Duke University Nitrosylated and nitrated superoxide oxidants and reductants
AU720686B2 (en) 1996-04-05 2000-06-08 General Hospital Corporation, The Treatment of a hemoglobinopathy
GB9801398D0 (en) * 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
SE9903985D0 (sv) * 1999-11-03 1999-11-03 Aga Ab Use of nitric oxide
CA2393724A1 (en) * 1999-12-23 2001-06-28 Nitromed, Inc. Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use

Also Published As

Publication number Publication date
IL153702A0 (en) 2003-07-06
WO2002000175A3 (en) 2002-08-15
AU2001273622B2 (en) 2007-05-10
KR100849103B1 (ko) 2008-07-30
US20030202969A1 (en) 2003-10-30
CN100488497C (zh) 2009-05-20
MXPA03000182A (es) 2004-02-26
CN1635923A (zh) 2005-07-06
EP1301076A2 (en) 2003-04-16
WO2002000175A2 (en) 2002-01-03
EP1301076A4 (en) 2004-09-22
US6935334B2 (en) 2005-08-30
JP2004509850A (ja) 2004-04-02
KR20030029530A (ko) 2003-04-14
AU7362201A (en) 2002-01-08
US6601580B1 (en) 2003-08-05

Similar Documents

Publication Publication Date Title
US6601580B1 (en) Enhancing therapeutic effectiveness of nitric oxide inhalation
AU2001273622A1 (en) Enhancing therapeutic effectiveness of nitric oxide inhalation
Roberts Jr et al. Inhaled nitric oxide in congenital heart disease.
Cepinskas et al. Inflammatory response in microvascular endothelium in sepsis: role of oxidants
Fullerton et al. Inhaled nitric oxide: therapeutic applications in cardiothoracic surgery
Lange et al. Role of nitric oxide in shock: the large animal perspective
US20040228930A1 (en) Treatment for hemorrhagic shock
Ullrich et al. Hypoxic pulmonary blood flow redistribution and arterial oxygenation in endotoxin-challenged NOS2-deficient mice
Roos et al. Chronic inhaled nitric oxide: effects on pulmonary vascular endothelial function and pathology in rats
CN100443119C (zh) 一氧化氮的吸入
Sheridan et al. Low-dose inhaled nitric oxide in acutely burned children with profound respiratory failure
Swenson et al. Effects of carbonic anhydrase inhibition on ventilation-perfusion matching in the dog lung.
Nguyen et al. Effects of manganese superoxide dismutase on lung fluid balance after smoke inhalation
Jones et al. NO: COPD and beyond
Oz et al. Collective review: perioperative uses of inhaled nitric oxide in adults
Enkhbaatar et al. Effect of inhaled nitric oxide on pulmonary vascular hyperpermeability in sheep following smoke inhalation
Abman et al. Inhaled nitric oxide therapy for pulmonary disease in pediatrics
Greene et al. The Efficacy of Inhaled Nitric Oxide in the Treatment of Acute Respiratory Distress Syndrome: An Evidence-Based Medicine Approach
ZA200300702B (en) Enhancing thereapeutic effectiveness of nitric oxide inhalation.
AU2007201877A1 (en) Enhancing therapeutic effectiveness of nitric oxide inhalation
Zapol et al. Inhaled nitric oxide in adult respiratory distress syndrome and other lung diseases
Cai et al. Nitric oxide in conjunction with milrinone better stabilized pulmonary hemodynamics after Fontan procedure
Hurford et al. Nitric oxide inhalation in the intensive care unit
Rossaint et al. Recent advances in the treatment of ARDS
Hurford et al. INHALED NO-HYPOTHESES

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued